Although rare, CBCD can be recognized through immunofluorescence and subsequently treated
Medical-Toxicological Knowledge Gaps Pose Challenges Despite Advances in Tattooing
The Cutaneous Connection: A Reminder of Patient Impact
MoonLake’s Sonelokimab Trial for HS Advances to Phase 3
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Lindus Health and Acinonyx Bio to Partner in Clinical Trial Evaluating a Benzoyl Peroxide Alternative
Soligenix Announces Publication of Promising Comparative Data for HyBryte Synthetic Hypericin for CTCL